Harvard Bioscience Inc. (HBIO)

The total asset value of Harvard Bioscience Inc (HBIO) stood at $ 127 Mln as on 31-Dec-24

The share price of Harvard Bioscience Inc (HBIO) is $0.40 (NASDAQ) as of 23-Apr-2025 14:37 EDT. Harvard Bioscience Inc (HBIO) has given a return of -58.97% in the last 3 years.

Harvard Bioscience Inc (HBIO) has a market capitalisation of $ 16 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.

Since, TTM earnings of Harvard Bioscience Inc (HBIO) is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Harvard Bioscience Inc (HBIO) and enter the required number of quantities and click on buy to purchase the shares of Harvard Bioscience Inc (HBIO).

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. Address: 84 October Hill Road, Holliston, MA, United States, 01746

The CEO & director of Mr. James W. Green. is Harvard Bioscience Inc (HBIO), and CFO & Sr. VP is Mr. James W. Green.

There is no promoter pledging in Harvard Bioscience Inc (HBIO).

Some of the close peers are:

No, TTM profit after tax of Harvard Bioscience Inc (HBIO) was $0 Mln.